GentiBio

Genti Bio

Biotechnology, 150 Cambridgepark Dr, Cambridge, Massachusetts, 02140, United States, 51-200 Employees

gentibio.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 19*********

Who is GENTIBIO

GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to...

Read More

map
  • 150 Cambridgepark Dr, Cambridge, Massachusetts, 02140, United States Headquarters: 150 Cambridgepark Dr, Cambridge, Massachusetts, 02140, United States
  • 2020 Date Founded: 2020
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies
  • Adel Nada CEO:   Adel Nada

industries-icon Industry: Biotechnology

SIC SIC Code: 7349

checked-icon Does something look wrong? Fix it. | View contact records from GENTIBIO

GentiBio Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding GentiBio

Answer: GentiBio's headquarters are located at 150 Cambridgepark Dr, Cambridge, Massachusetts, 02140, United States

Answer: GentiBio's phone number is 19*********

Answer: GentiBio's official website is https://gentibio.com

Answer: GentiBio's revenue is $25 Million to $50 Million

Answer: GentiBio's SIC: 7349

Answer: GentiBio has 51-200 employees

Answer: GentiBio is in Biotechnology

Answer: GentiBio contact info: Phone number: 19********* Website: https://gentibio.com

Answer: GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access